Hao GM

No ORCID on file · 11 papers in corpus · active 2019-2026

Study types

  • article 1
  • other 1

Condition tags

  • infertility 4
  • endometriosis 2
  • endometrioma 1
2026
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2026.1746912

Research questionEmbryo quality serves as a pivotal determinant in assisted reproductive technology (ART) outcomes, with high-grade embryos correlating with improved pregnancy/live birth rates but poor morphology elevating the risks of impl…

2026
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2026.1758224

ObjectiveThis study aims to assess the effects of intrauterine infusion of human umbilical cord blood mononuclear cells (HUCBMCs) on reproductive outcomes in patients with thin endometrium undergoing frozen embryo transfer (FET).DesignProsp…

2024
Asian journal of andrology ·doi:10.4103/aja202329

The sperm DNA fragmentation index (DFI) is a metric used to assess DNA fragmentation within sperm. During in vitro fertilization-embryo transfer (IVF-ET), high sperm DFI can lead to a low fertilization rate, poor embryo development, early m…

other 2024
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-024-01273-z

DNA damage is a key factor affecting gametogenesis and embryo development. The integrity and stability of DNA are fundamental to a woman's successful conception, embryonic development, pregnancy and the production of healthy offspring. Agin…

2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.915923

ObjectiveThe aim of this study is to investigate the optimal estradiol (E2) level on the day of gonadotropin-releasing hormone antagonist (GnRH-ant) initiation to maximize the clinical pregnancy rate (CPR) after fresh embryo transfer among …

article 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.798434

OBJECTIVE: To evaluate the pregnancy outcomes of progestin-primed ovarian stimulation (PPOS) protocol for patients with endometrioma underwent in vitro fertilization/intra-cytoplasmic sperm injection embryo transfer (IVF/ICSI-ET). DESIGN: …

2021
Scientific reports ·doi:10.1038/s41598-021-94366-3

Bushen-Tiaojing-Fang (BSTJF) is commonly used to treat infertility. This study investigated the effects of BSTJF on the pregnancy outcomes of patients with repeated controlled ovarian stimulation (COS), on mitochondrial function, and on oxi…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.676133

Letrozole, an aromatase inhibitor that blocks estrogen synthesis by inhibiting the final step of the estrogen biosynthetic pathway, has been used in the applications of a wide range of infertility settings. It has been more than 20 years si…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.683236

ObjectiveTo evaluate the risk factors for different types of pregnancy losses after embryo transfer (ET).DesignRetrospective cohort study.SettingReproductive medicine center.ParticipantsA total of 15,210 pregnancies after fresh and frozen-t…

2020
Scientific reports ·doi:10.1038/s41598-020-75124-3

This study was to retrospectively analyze the effect of the age of embryos transfer and oocyte retrieval on the clinical pregnancy outcome in patients with simple tubal factor infertility (TFI) who received frozen-thawed embryo transfer. Pa…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00502

Growth hormone (GH) is a peptide hormone secreted mainly by the anterior part of the pituitary gland and plays a critical role in cell growth, development, and metabolism throughout the body. GH can not only directly influence human oocytes…